Sentences with phrase «most vaccine development»
The flurry of action — at breakneck speed compared with most vaccine development — shows how a health emergency and a guaranteed global market can prod this process to move a lot faster than usual, with streamlined approvals and millions of dollars in government support.
https://www.scientificamerican.com/ Not exact matches
Next year, UTMB will start building a high - containment lab that can handle even the most dangerous viruses — one of only a handful in the U.S. With that capacity, and the expertise concentrated at UTMB, the new center should «make some very important contributions» to vaccine development, La Montagne predicts.
But scientific and economic obstacles have stymied the development of effective vaccines against many of the developing world's most deadly diseases, such as malaria and HIV as well as pneumococcus, the leading vaccine - preventable killer of children under the age of five.
The cells have contributed to more than 60,000 research papers, the development of a polio vaccine in the 1950s and, most recently, an international effort to characterize the genome, known as ENCODE.
With most of these firms or their vaccine subsidiaries based in Europe, this makes the continent home to 90 per cent of global vaccine production and nearly half of its R&D (Drug Development and Delivery, vol 11, p 26).
That process faces the same development delays as in 2009, when vaccine arrived too late for most people.
Ahead of this year's World Immunization Week — celebrated in the last week of April — we're reviewing some of the most important vaccine breakthroughs in recent history, as well as a looking to the future of vaccine development for diseases like HIV / AIDS, Zika, and Herpes.
Dr. Polonis has spent most of her 28 years of research experience associated with the Military HIV Research Program and focusing on HIV vaccine development.
As the single most important cause of serious lower respiratory tract disease in infants and young children in the United States and globally, RSV is of considerable public health importance and a high priority for vaccine development.
Smallpox has been all but eradicated in the West thanks to the development of a vaccine (which most of our parents had).
We could be much closer to the development of a vaccine against RSV, the most important viral cause of pneumonia and wheezing illness in infants and young children all over the world.
Since that post, there have been exciting developments in the progress of the two most advanced of these immunotherapies: PD01A, the AS - targeting active vaccine from Austrian biotechnology startup AFFiRiS AG, developed using its patented «AFFITOME» neo-antigen discovery platform of molecular mimicry; and PRX002, a humanized monoclonal Ab (mAb) under development from Prothena Corp PLC, the successor of aggregate - clearing immunotherapy pioneer Élan Pharmaceuticals.
Scientists and vaccine developers involved in EVI projects presented project progress and research findings, highlighting one of the most important areas of EVI's activities; translation of research on diseases of poverty vaccines, focusing on early stages from preclinical to clinical development through harmonisation.
Trained as a physician, specialised in epidemiology, clinical pharmacology and vaccinology, Dr Odile Leroy has spent most of her carrier in vaccine development, as a scientist in Africa for nine years, as corporate clinical director of airborne vaccines for 10 years at Sanofi Pasteur.
In September 2017, the two received the Lasker - DeBakey Clinical Medical Research Award, the country's most prestigious honor for biomedical research, for their significant research leading to the development of HPV vaccines.
Most recently, CRI has launched a new «venture philanthropy» program called the Cancer Vaccine Acceleration Fund (CVAF) as a means to catalyze development of next - generation therapeutic cancer vaccines and other immunotherapies by helping to address the critical shortage of capital available for early stage clinical trials.
A good knowledge of correlates of protection could predict the efficacy of novel vaccines at early stages of development and help identify the most promising candidates for vaccine trials.
The most famous, oldest, and most commonly used immortal cell line, dubbed HeLa, originated in a tumor sample taken from an African - American woman, Henrietta Lacks, who is the subject of the recent book The Immortal Life of Henrietta Lacks.9 The tumor cells, harvested at Johns Hopkins Hospital, gave rise to the eponymous HeLa cell line which researchers have used continuously since her death in 1951 for numerous experiments, including Jonas Salk's development of the polio vaccine.
Once I came to the conclusion that there was no valid reason for most yearly pet vaccines — and there was a possibility that vaccines could trigger the development of serious diseases — I felt I could no longer work at a conventional veterinary clinic.
Still Important Today Despite the development of excellent and safe vaccines against rabies, every 10 minutes, somewhere in the world, a person dies of rabies, most of them children.